Driving Innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of pharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ innovative companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. Read more…

Upcoming Events

2
Jun

2. June 2022 — Register Here

Bulgarian Association for Drug Information (BADI) – Annual Conference

The Bulgarian Association for Drug Information (BADI) will host its annual conference on “Revolution in Regulatory Affairs – How the pandemic is shaping the regulatory field and sciеnce.” EUCOPE’s Alexander Natz will speak at the 14:45 session “The Implications Of The New EU HTA Regulation… read more

7
Jun

7. June 2022 — Register Here

‘Piloting the EU HTA before 2025 – Opportunities for companies to engage’

Join Flora Giorgio, Deputy Head of Unit, B6 Medical Devices and HTA, DG SANTE, European Commission, Adam Parnaby, Vice-Chair EFPIA HTA WG & Senior Director, Market Access Policy, BMS, Alexander Natz, Secretary-General, EUCOPE and Christian Hill, Founder and Chief Strategy Officer, MAP Patient Access as they discuss piloting the EU HTA… read more

27
Jun

27. June 2022 — Register Here

11th European Conference on Rare Diseases & Orphan Products (ECRD 2022)

The European Conference on Rare Diseases & Orphan Products (ECRD) is the largest, patient-led rare disease event in which collaborative dialogue, learning, and conversation takes place, forming the groundwork to shape goal-driven rare disease policies and allow for important and innovative discussions on a national… read more

11
Jul

11. July 2022 to 13. July 2022 — Register Here

World Orphan Drug Congress USA 2022

The World Orphan Drug Congress USA brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving… read more

11
Jul

11. July 2022 to 13. July 2022 — Register Here

3rd Gene Therapy for Neurological Disorders Europe

Don’t miss your chance to join Europe’s only industry-focused event specifically dedicated to overcoming the niche challenges of targeting the CNS with gene therapy. Access NEW content such as sharing MHRA insights on regulatory challenges, addressing Europe’s payer considerations with the NHS, discussing specific European clinical trial nuances and hearing from Europe’s leading neurosurgeons… read more

26
Oct

26. October 2022 — Register Here

Nordic Growth Summit

Back Bay Life Science Advisors together with the Innovation Centre Denmark is pleased to welcome you to the Nordic Growth Summit, a day of international collaboration. The Nordic Growth Summit is a gathering of biopharma, medtech and healthtech organizations leading Scandinavian life sciences and collectively… read more

8
Nov

8. November 2022 to 9. November 2022

8th Annual World Cancer Series: Europe 2022

The 8th Annual World Cancer Series Europe will convene a wide range of stakeholders critical to effective cancer control: policymakers, healthcare professionals and providers, regulators, payers, investors, industry and of course patient groups. The focus of this year’s conference is ”innovation, equity and excellence.” The… read more

14
Nov

14. November 2022 to 17. November 2022 — Register Here

World Orphan Drug Conference EU

The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe. Now in its 13th annual edition, the World Orphan Drug Congress… read more

29
Nov

29. November 2022 to 30. November 2022

DIA-EUCOPE Innovative Therapies in Europe Workshop and the pre-conference tutorial: Transforming Value into Access during Payer Negotiations 

EUCOPE is co-hosting a pre-conference tutorial and workshop at the IDA Innovative Therapies in Europe event. Over two days, key stakeholders and participants will discuss and share practical experiences on: how to create a negotiation pathway to increase the likelihood of reaching an agreement on… read more

News & Updates

🎙️Sounds of Science Podcast – Episode 5 on Increasing Access to Genomic Testing in Europe

As the science around genomics continues to evolve, advanced diagnostics technologies are delivering benefits to today’s patients while supporting future research and clinical development. However, beyond research programmes, many of these technologies are not reaching patients in clinical routine care in Europe. Patients’ health outcomes… read more

PharmaBoardroom Opinion: New EU HTA Procedure – Will it Reduce the Complexity and Burdens for Manufacturers?

This article originally featured in PharmaBoardroom. You can find the original article here.  EUCOPE’s Secretary-General Dr. Alexander Natz sees both opportunities and pitfalls with the EU HTA procedure, saying that the next three years will decide the crucial steps and whether the new procedure leads… read more

EUCOPE Member Spotlight: Q&A with MorphoSys

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In April, we spoke with Malte Peters, M.D., Chief Research and Development Officer, MorphoSys. Dr. Malte Peters joined MorphoSys in… read more

EUCOPE’s reaction to the Regulation for a European Health Data Space (EHDS)

Yesterday, 3 May 2022, the European Commission published the proposal for a regulation introducing the European Health Data Space (EHDS). First introduced on the 16th of September by the European Commission President Ursula von der Leyen, the Commission aims for the EHDS to form a… read more

EUCOPE Member Spotlight: Q&A with Jazz Pharmaceuticals

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In April, we spoke with Chris Tovey, Executive Vice President and Chief Operating Officer and Managing Director, Europe &… read more

On the upcoming Regulation Proposal on the European Health Data Space (EHDS)

  On 16 September 2020, Ursula von der Leyen, European Commission President, announced a new legislative proposal to create a European Health Data Space in her State of the Union address. The European Health Data Space (EHDS) is a key element of the European Health… read more

Partnerships in Focus: Q&A with Takeda’s Toon Digneffe

At EUCOPE, our commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve and healthcare systems overall. Through our Partnerships in Focus series, we’ll be highlighting different associates that we… read more

Modernising the Centralised Procedure: Our Proposal for Reform

EUCOPE’s latest position paper outlines our vision for the evolution of the EU Regulatory framework and a modernisation of the Centralised Procedure to ultimately bring novel medicines earlier to patients. The European Centralised Procedure (CP) has helped and accelerated the approval of novel medicines across… read more

The Implications Of The New EU HTA Regulation For Companies

Joint Clinical Assessments Will Become A Key Part Of The New Environment Regulation (EU) 2021/2282 on health technology assessment (HTA) is now in force and will bring important and wide-reaching changes that pharmaceutical companies need to understand. Arguably the most important implication of the regulation… read more

EUCOPE adds five new members to its association

As the EU trade body for small to mid-sized companies that support, invest and produce the innovative medicines and therapies of the future, EUCOPE is happy to welcome five new members to its organisation. AOP Health, Enterome, Flatiron Health, Novo Nordisk and TETEC all became… read more

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership